The latest announcement is out from Adicet Bio ( (ACET) ).
Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback